These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

5490 related articles for article (PubMed ID: 3131777)

  • 21. Loss of melanogenic properties in tyrosinases induced by glucosylation inhibitors within malignant melanoma cells.
    Imokawa G; Mishima Y
    Cancer Res; 1982 May; 42(5):1994-2002. PubMed ID: 6802485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of tyrosinase activity and viral information by 5-iodo-deoxyuridine and L-dopa in a human melanoma cell line [proceedings].
    Van Tieghem N; Doyen A; Liteanu D; Cogniaux J; Frühling J
    Arch Int Physiol Biochim; 1979 Oct; 87(4):857-8. PubMed ID: 93948
    [No Abstract]   [Full Text] [Related]  

  • 23. [Malignant melanoma--a PO-cell tumor? (author's transl)].
    Schmidt H; Stintz AR
    Arch Geschwulstforsch; 1975; 45(2):146-52. PubMed ID: 812451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tyrosinase activity in primary cell culture of amelanotic melanoma cells.
    Słomiński A; Scisłowski PW; Bomirski A
    Biosci Rep; 1983 Nov; 3(11):1027-34. PubMed ID: 6140964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The hydroxyl radical is not involved with tyrosinase inactivation.
    Tomita Y; Seiji M; Igarashi A
    J Dermatol; 1980 Oct; 7(5):377-80. PubMed ID: 6782145
    [No Abstract]   [Full Text] [Related]  

  • 26. [Investigation of tyrosinase activity and phospholipid composition in Harding-Passey melanoma microsomal fraction].
    Shtol'ko VN; Bogdanov GN; Vasil'eva LS; Burlakova EB
    Biokhimiia; 1978 Jan; 43(1):121-6. PubMed ID: 414789
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of imidazole-induced tyrosinase activity by estradiol and estriol in cultured B16/C3 melanoma cells.
    Kline EL; Smith TJ; Carland KA; Blackmon B
    J Cell Physiol; 1988 Mar; 134(3):497-502. PubMed ID: 3127403
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of L-glutamine on tyrosinase and gamma-glutamyl transpeptidase of B-16 melanoma cells in culture.
    Chakraborty C; Hatta S; Ichihashi M; Hayashibe K; Mishima Y
    J Dermatol; 1988 Feb; 15(1):1-6. PubMed ID: 2899096
    [No Abstract]   [Full Text] [Related]  

  • 29. NIH peer review favoritism: lavish financial support for questionable old concept of mammalian melanogenesis; absence of support for work based on new concept.
    Okun MR; Edelstein LM; Patel RP
    Physiol Chem Phys; 1976; 8(2):177-86. PubMed ID: 824659
    [No Abstract]   [Full Text] [Related]  

  • 30. Tyrosinase activity and abundance in Cloudman melanoma cells.
    Halaban R; Pomerantz SH; Marshall S; Lerner AB
    Arch Biochem Biophys; 1984 Apr; 230(1):383-7. PubMed ID: 6201140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oxidation of carbidopa by tyrosinase and its effect on murine melanoma.
    Gasowska-Bajger B; Frackowiak-Wojtasek B; Koj S; Cichoń T; Smolarczyk R; Szala S; Wojtasek H
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3507-10. PubMed ID: 19457668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of actinomycin D and cycloheximide on the increase in tyrosinase activity of hamster amelanotic melanoma cells in vitro.
    Słomiński A; Bomirski A; Scisłowski PW; Zołnierowicz S
    Biosci Rep; 1984 Dec; 4(12):1059-64. PubMed ID: 6442169
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potentiation by alpha-difluoromethylornithine of the activity of 3,4-dihydroxybenzylamine, a tyrosinase-dependent melanolytic agent, against B16 melanoma.
    Prakash NJ; Sunkara PS; Sjoerdsma A
    Biochem Pharmacol; 1985 Jun; 34(11):1887-90. PubMed ID: 3924051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [GERL-coated vesicle system in the melanin synthesizing cell: its three-dimensional ultrastructure and tyrosinase activity (author's transl)].
    Ogura H; Mishima Y
    Nihon Hifuka Gakkai Zasshi; 1977 Nov; 87(13):883-901. PubMed ID: 413959
    [No Abstract]   [Full Text] [Related]  

  • 35. Retinoic acid blockade of imidazole-induced tyrosinase expression in B16 melanoma cultures: similar effects of the active retinoid and triiodothyronine.
    Smith TJ; Warren JT; Kline EL
    Biochem Biophys Res Commun; 1989 Jul; 162(1):288-93. PubMed ID: 2502111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of melanocytolytic agents and other compounds upon dominant human melanoma tyrosinase activity.
    Chen YM; Chavin W
    Experientia; 1978 Jan; 34(1):21-2. PubMed ID: 413735
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological determination of tyrosinase in sera of melanoma-bearing hamsters.
    Dernałowicz-Malarczyk E; Kotłowska-Niećko I
    Neoplasma; 1980; 27(4):345-53. PubMed ID: 6779209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Histochemical phenoloxidase demonstration in tumors of the melanocytic system].
    Schmidt H; Wagner U
    Acta Histochem; 1986; 79(1):23-31. PubMed ID: 3090836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Demonstration of a tyrosinase type activity in Kupffer cells of Rana esculenta L].
    Cicero R; Maida I; Mallardi A; Pintucci G; Gallone A
    Boll Soc Ital Biol Sper; 1988 Mar; 64(3):203-10. PubMed ID: 3142500
    [No Abstract]   [Full Text] [Related]  

  • 40. Mammalian tyrosinase: isolation by a simple new procedure and characterization of its steric requirements for cofactor activity.
    Hearing VJ; Ekel TM; Montague PM; Hearing ED; Nicholson JM
    Arch Biochem Biophys; 1978 Jan; 185(2):407-18. PubMed ID: 415664
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 275.